🤝
Make a deal with Saloni
🔒 Paid proposals held safely in escrow — released only when the work's approved.
Followers
44.8K
Account age
3 yrs
💰 Suggested sponsorship rate
$251 – $408 / sponsored post
Estimated from audience size & typical reach — every deal is negotiable and held in SocialDB escrow.
🧰 Free analysis for Saloni
Known for
22 views
I love this clip of @jacobtref.bsky.social on the wonder of drug repurposing in the RECOVERY trial:
📊 Post engagement
61
Avg engagement / post
0.1%
Engagement vs followers
May 2023
On Bluesky since
🔥 Top post: These backronyms need to STOP (Seriously this isn'T funny Or apP · 153 likes + reposts
📊 Activity & format
Posting cadence
10.5 / week
Posts daily — consistently active for a campaign window.
Content mix
Mostly text
Recent: 7 text · 4 image · 1 video.
Recent posts
View on Bluesky ↗
Nice piece by @wilsonmking.bsky.social on a surprisingly unsolved question: Why are Indian kids so short? (Even more than India's development would imply.)
It felt a bit voyeuristic to me though, like reading about myself or something.
This is a really beautiful website by @jdworkin.bsky.social on the everyday household items that were once only dreamt about – a music player, nightlight, family photos, clean water, ice, spices, and more.
10/10 would recommend exploring …
I'm interested in finding and potentially supporting people who are interested in doing long-form writing on the big efforts in global health: Gavi, Global Fund, PEPFAR, etc.
If this is you or someone you know, please make yourself known!
▶
I love this clip of @jacobtref.bsky.social on the wonder of drug repurposing in the RECOVERY trial:
Tune in to hear about: Immortal time bias, confounding by selection, regression discontinuities, platform trials, the uncanny mountain of p-values, high-throughput screening, patent and exclusivity laws, push vs pull funding, indication-ba…
Photo post
New episode of HARD DRUGS!
GLP1 drugs have transformed obesity & diabetes, help treat heart disease, kidney disease and sleep apnea.
They're far from the only drug with multiple uses. But sometimes, it takes several decades - and public …
Kalshi recently opened prediction betting markets for clinical trials and drug approvals.
It's intriguing, but in my view also risks weakening the integrity of trials and worsening participant dropouts.
Short post by me:
Amazed this is real
Strep A kills hundreds of thousands of people per year, but there's no vaccine for it – yet.
Some of my wonderful colleagues at Coefficient Giving and lots of great scientists are trying to change that.
Please share this with researcher…
I just noticed that Naomi Wolf, of all people, follows me on Substack 😂
I wonder what she gets out of it.
Maybe she's interested in the latest developments in time travel technology.
▶
I love this clip of @jacobtref.bsky.social on the wonder of drug repurposing in the RECOVERY trial:
Tune in to hear about: Immortal time bias, confounding by selection, regression discontinuities, platform trials, the uncanny mountain of p-values, high-throughput screening, patent and exclusivity laws, push vs pull funding, indication-ba…
🦋 Handle & authenticity
✅ Domain-verified
@scientificdiscovery.dev
The handle is the domain scientificdiscovery.dev. On Bluesky a domain handle proves the owner controls that website — so this is verifiably the real scientificdiscovery.dev account, not an impersonator.
On Bluesky since
May 2023
An early adopter from the invite-only beta (before the Feb 2024 public launch) — an original, established account.
💡 Facts
🗓️Joined Bluesky in 2023 — 3 years ago.
👁️Averages 61 views per post.
📤Posts about 10.5× per week.
🏅Earned the 10K Followers for passing 10K followers.
🕵️ Fake follower check
Estimated52/100
Fair
Credibility score
76%
Mixed
Real audience
Medium
Fake-follower risk
Medium
Data confidence
- Est. 76% real, active audience · Medium fake-follower risk.
- Low engagement (~0.1% of followers engage each post) — a sign of an inflated or inactive audience.
- Verified account.
- Established account (3+ years old).
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
Co-founder & editor, Works in Progress. Writer, Scientific Discovery. Podcaster, Hard Drugs. Advisor, Coefficient Giving. // Previously at Our World in Data.
Newsletter: https://scientificdiscovery.dev
Podcast: https://harddrugs.worksinprogress.co
🏳️🌈
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
More like this
Find more →
Bluesky
Rob Bon Vivant🌊
@77sunnyandclear.bsky.social
44.8K
Followers
Bluesky
Survival mode💙
@equestrian34.bsky.social
44.8K
Followers
Bluesky
The Narwhal ✓
@thenarwhal.ca
44.8K
Followers
Bluesky
Michael ❌👑 Indivisible COLO
@michaelindivisible.bsky.social
44.8K
Followers
Bluesky
Legrand Wolf
@legrandwolf.bsky.social
44.8K
Followers
Bluesky
Sasquatch_Gains
@sasquatchgains.bsky.social
44.8K
Followers
✉ Message Saloni
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Saloni
Booking an event / appearance is a Pro feature. Upgrade to book Saloni for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Saloni gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
🚀
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.
Auto-generated from Bluesky's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove